Memoplant, 40 mg 60 pcs

Memoplant is a regulator of peripheral blood circulation, improving the cerebral circulation.

Pharmacodynamics

The drug of plant origin increases the resistance of the body, especially brain tissue, to hypoxia inhibits the development of traumatic or toxic cerebral edema, improves the cerebral and peripheral blood circulation, improves blood rheology.

It has a dose-dependent regulatory effect on the vascular system, dilates small arteries and increases the tone of veins. Prevents the formation of free radicals and lipid peroxidation in cell membranes.

Normalizes the release, re-uptake and catabolism of neurotransmitters (norepinephrine, dopamine, acetylcholine) and their ability to combine with receptors. It improves metabolism in organs and tissues, contributes to the accumulation of macroergens in cells, increases the utilization of oxygen and glucose, and normalizes mediator processes in the CNS.

Indications

disorders of brain function (including age-related) associated with cerebral circulation, accompanied by symptoms such as memory impairment, decreased ability to concentrate and intellectual abilities, dizziness, tinnitus, headache;
peripheral circulatory disorders: obliterating diseases of the arteries of the lower extremities with such characteristic symptoms as intermittent claudication, numbness and coldness of the feet, Raynaud’s disease;
dysfunction of the inner ear, manifested by dizziness, unsteady gait and tinnitus.

Pharmacological effect

Memoplant – regulates peripheral blood circulation, improves cerebral circulation.

Pharmacodynamics

The drug of plant origin increases the resistance of the body, especially brain tissue, to hypoxia, inhibits the development of traumatic or toxic cerebral edema, improves cerebral and peripheral blood circulation, and improves blood rheology.

It has a dose-dependent regulatory effect on the vascular system, dilates small arteries, and increases the tone of the veins. Prevents the formation of free radicals and lipid peroxidation of cell membranes.

Normalizes the release, re-uptake and catabolism of neurotransmitters (norepinephrine, dopamine, acetylcholine) and their ability to bind to receptors. Improves metabolism in organs and tissues, promotes the accumulation of macroergs in cells, increases the utilization of oxygen and glucose, and normalizes mediator processes in the central nervous system.

Special instructions

If you experience frequent feelings of dizziness and tinnitus, as well as in case of sudden deterioration or loss of hearing, you should immediately consult your doctor.

Active ingredient

Ginkgo biloba leaf extract

Composition

Active ingredient:

ginkgo biloba leaf dry extract EGb761® (35–67:1) 120 mg,

extractant – acetone 60% (standardized for the content of ginkgoflavone glycosides – 28.8 mg and terpene lactones – 7.2 mg);

Excipients:

lactose monohydrate – 68.25 mg;

colloidal silicon dioxide – 3 mg;

MCC – 163.5 mg;

corn starch – 15 mg;

croscarmellose sodium – 15 mg;

stearate – 5.25 mg;

Film casing:

hypromellose – 11.5728 mg; macrogol 1500 – 5.7812 mg; defoaming emulsion SE2 – 0.015 mg; titanium dioxide (E171) – 1.626 mg; iron oxide red (E172) – 1.3 mg; talc – 0.72 mg

Contraindications

hypersensitivity to the components of the drug;
decreased blood clotting;
erosive gastritis;
peptic ulcer of the stomach and duodenum in the acute stage;
acute cerebrovascular accidents;
acute myocardial infarction;
patients with congenital galactosemia, glucose or galactose malabsorption syndrome, or congenital lactase deficiency (the drug contains lactose);
children under 18 years of age (insufficient data on use).

Side Effects

Allergic reactions are possible (redness, skin rash, swelling, itching); in rare cases – gastrointestinal disorders (nausea, vomiting, diarrhea); headache, hearing impairment, dizziness, decreased blood clotting.

Isolated cases of bleeding have been observed in patients who were simultaneously taking anticoagulants (the cause-and-effect relationship of bleeding with taking Ginkgo biloba EGb 761® has not been confirmed).

If any adverse events occur, you should stop taking the drug and consult your doctor.

Interaction

It is not recommended to prescribe Memoplant to patients constantly taking acetylsalicylic acid, anticoagulants (direct and indirect action), as well as other drugs that reduce blood clotting.

Storage conditions

At 15–25 °C

Shelf life

5 years

Manufacturer

Dr. Wilmar Schwabe GmbH & Co. KG, Germany